| ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
GABBR1 |
GABBR1, GPRC3A: Gamma-aminobutyric acid type B receptor subunit 1 precursor |
0.47 |
Evidence |
|
| ADAM15 |
ADAM15, MDC15: ADAM 15 precursor |
PARD6G |
PARD6G, PAR6G: Partitioning defective 6 homolog gamma |
0.47 |
Evidence |
|
| STX3A |
STX3, STX3A: Syntaxin-3 |
TRIM39 |
TRIM39, RNF23, TFP: Tripartite motif-containing protein 39 |
0.47 |
Evidence |
|
| STX3A |
STX3, STX3A: Syntaxin-3 |
ITSN1 |
ITSN1, ITSN, SH3D1A: Intersectin-1 |
0.47 |
Evidence |
|
| STX4A |
STX4, STX4A: Syntaxin-4 |
TRIM39 |
TRIM39, RNF23, TFP: Tripartite motif-containing protein 39 |
0.47 |
Evidence |
|
| STX4A |
STX4, STX4A: Syntaxin-4 |
ITSN1 |
ITSN1, ITSN, SH3D1A: Intersectin-1 |
0.47 |
Evidence |
|
| PAX5 |
PAX5: Paired box protein Pax-5 |
STAT3 |
|
0.47 |
Evidence |
|
| RELB |
RELB: Transcription factor RelB |
STAT3 |
|
0.47 |
Evidence |
|
| YWHAG |
YWHAG: 14-3-3 protein gamma |
USP52 |
IPI00328254 |
0.47 |
Evidence |
|
| AMPH |
AMPH, AMPH1: Amphiphysin |
DUSP4 |
DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 |
0.47 |
Evidence |
|
| LSP1 |
LSP1, WP34: Lymphocyte-specific protein 1 |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
0.47 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
PRKACG |
PRKACG: cAMP-dependent protein kinase, gamma-catalytic subunit |
0.47 |
Evidence |
|
| CAPN3 |
CAPN3, CANP3, CANPL3, NCL1: Calpain-3 |
REL |
REL: C-Rel proto-oncogene protein |
0.47 |
Evidence |
|
| HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
MAPK15 |
IPI00395861 |
0.47 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
TAAR9 |
TAAR9, TA3, TAR3, TRAR3: Trace amine-associated receptor 9 |
0.47 |
Evidence |
|
| DSP |
DSP: Desmoplakin |
TNPO1 |
|
0.47 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
PLCD1 |
DKFZp686K101: Putative uncharacterized protein DKFZp686K101 |
0.47 |
Evidence |
|
| ICAM2 |
ICAM2: Intercellular adhesion molecule 2 precursor |
ASB12 |
ASB12: Ankyrin repeat and SOCS box protein 12 |
0.47 |
Evidence |
|
| ICAM2 |
ICAM2: Intercellular adhesion molecule 2 precursor |
ASB17 |
ASB17: Ankyrin repeat and SOCS box protein 17 |
0.47 |
Evidence |
|
| VIM |
VIM: Vimentin |
SMURF2 |
SMURF2: E3 ubiquitin-protein ligase SMURF2 |
0.47 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
DUSP10 |
DUSP10, MKP5: Dual specificity protein phosphatase 10 |
0.47 |
Evidence |
|
| LPL |
LPL, LIPD: Lipoprotein lipase precursor |
GPR133 |
GPR133, PGR25: Probable G-protein coupled receptor 133 precursor |
0.47 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
PTPRD |
PTPRD: PTPRD protein |
0.47 |
Evidence |
|
| APCS |
APCS, PTX2: Serum amyloid P-component precursor |
KIAA0247 |
KIAA0247: Uncharacterized protein KIAA0247 precursor |
0.47 |
Evidence |
|
| CCNE2 |
CCNE2: G1/S-specific cyclin-E2 |
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
0.47 |
Evidence |
|